Anti-Siglec-2 / CD22 Reference Antibody (pinatuzumab vedotin)

• Catalog Number: orb1818304
• Category: Antibodies
• Description: Recombinant Antibody
• Clonality: Monoclonal
• Tested applications: ELISA, FC
• Reactivity: Human, Monkey, Rat
• Isotype: IgG1
• Antibody Type: Primary Antibody
• Concentration: 1mg/ml
• Form/Appearance: Purified monoclonal antibody supplied in PBS, pH 6.0, without preservative.This antibody is purified through a protein A column.
• Conjugation: Unconjugated
• MW: 151.97
• UniProt ID: P20273
• Protein Sequence: Siglec-2 / CD22
• Expression System: CHO Cell
• Endotoxins: < 0.001EU/μg,determined by LAL method.
• Alternative names: B-cell receptor CD22, B-lymphocyte cell adhesion m
• Note: For research use only
• Expiration Date: 12 months from date of receipt.

The purity of Anti-Siglec-2 / CD22 Reference Antibody (pinatuzumab vedotin) is more than 95%, determined by SEC-HPLC.

Immobilized human Siglec 2 / CD22, His Tag at 2 µg/mL can bind Anti-Siglec-2 / CD22 Reference Antibody (pinatuzumab vedotin), EC50=0.008851 µg/mL

Anti-Siglec-2 / CD22 Reference Antibody (pinatuzumab vedotin) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%